These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1524961)

  • 41. Bioequivalence of different prednisolone tablet formulations.
    Luippold G; Benöhr P; Schneider S; Marto M; Mühlbauer B
    Arzneimittelforschung; 2001; 51(8):638-42. PubMed ID: 11556124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic comparison of two valproic acid formulations--a plain and a controlled release enteric-coated tablets.
    Rha JH; Jang IJ; Lee KH; Chong WS; Shin SG; Lee N; Myung HJ
    J Korean Med Sci; 1993 Aug; 8(4):251-6. PubMed ID: 8198761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative bioavailability of two enteric-coated tablet preparations of diclofenac sodium.
    Paton DM
    Int J Clin Pharmacol Res; 1987; 7(4):239-42. PubMed ID: 3596865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic interaction between endogenous cortisol and exogenous corticosteroids.
    Rohatagi S; Hochhaus G; Möllmann H; Barth J; Derendorf H
    Pharmazie; 1995 Sep; 50(9):610-3. PubMed ID: 7480097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioavailability of prednisolone in asthmatic patients with a poor response to steroid treatment.
    Mortimer O; Grettve L; Lindström B; Lönnerholm G; Zetterström O
    Eur J Respir Dis; 1987 Nov; 71(5):372-9. PubMed ID: 3443161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of prednisone and prednisolone in a case of hypothyroidism: effect of replacement therapy.
    Bergamaschi S; Rusconi R; Gervasoni M; Rigamonti AE; Cella S; Bareggi SR
    Steroids; 2005 Oct; 70(11):787-9. PubMed ID: 16045952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft.
    Neumann I; Fuhrmann H; Kanzler M; Fang IF; Jaeger A; Graf H; Bayer P; Kovarik J
    Expert Opin Pharmacother; 2008 Apr; 9(6):879-86. PubMed ID: 18377332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steady-state pharmacokinetics of enteric-coated naproxen tablets compared with standard naproxen tablets.
    Jung D; Schwartz KE
    Clin Ther; 1994; 16(6):923-9. PubMed ID: 7697688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
    Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
    Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
    Bonn M; Eydeler U; Barkworth M; Rovati LC
    Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration].
    Brion N; Pibarot ML; Atienza P; Robin P; Carbon C
    Presse Med; 1988 Apr; 17(12):569-71. PubMed ID: 2967477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malabsorption of prednisolone from enteric-coated tablets after ileostomy.
    Al-Habet S; Kinsella HC; Rogers HJ; Trounce JR
    Br Med J; 1980 Sep; 281(6244):843-4. PubMed ID: 7427477
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of enteric coated prednisolone in Crohn's disease.
    Beattie RM; Walker-Smith JA
    Arch Dis Child; 1994 Sep; 71(3):282. PubMed ID: 7979514
    [No Abstract]   [Full Text] [Related]  

  • 54. [RU 28965, a new semi-synthetic macrolide. Bioavailability and pharmacokinetic profile after oral administration].
    Tremblay D; Bryskier A; Vuckovic M; Stockis A; Manuel C
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):502-6. PubMed ID: 3911143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is it possible to achieve bio-equivalence between an oral solid immediate-release and an analogue enteric-coated formulation?
    Licht D; Cohen R; Spiegelstein O; Rabinovich-Guilatt L; Zholkovsky M; Gilbert A; Dressman JB; Safadi M
    J Pharm Pharmacol; 2016 Oct; 68(10):1278-89. PubMed ID: 27465906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absorption of enteric-coated prednisolone.
    Fernando ON; Moorhead J
    Br Med J; 1979 Jun; 1(6180):1795. PubMed ID: 466230
    [No Abstract]   [Full Text] [Related]  

  • 57. Enteric-coated insulin capsules: a combination with or a replacement of oral hypoglycaemic drugs.
    Hosny EA; el-Bagory IM; al-Jenoobi FI
    Boll Chim Farm; 2002; 141(5):379-84. PubMed ID: 12481381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma steroid levels after intra-articular injection of prednisolone acetate in patients with rheumatoid arthritis.
    Reeback JS; Chakraborty J; English J; Gibson T; Marks V
    Ann Rheum Dis; 1980 Feb; 39(1):22-4. PubMed ID: 7377855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.
    Wald JA; Law RM; Ludwig EA; Sloan RR; Middleton E; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Dec; 20(6):567-89. PubMed ID: 1302763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of enteric coated tablet sensitive to pancreatic lipase. II. In vivo evaluation.
    Yoshitomi H; Shizuku Y; Masuda Y; Itakura R; Okamoto S; Tomida H; Nishihata T; Goto S
    Biol Pharm Bull; 1993 Dec; 16(12):1260-3. PubMed ID: 8130777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.